| Drug Name: | Sulindac (38194-50-2) |
|---|---|
| PubChem ID: | 1548887 |
| SMILES: | CC1=C(C2=C(/C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O |
| InchiKey: | MLKXDPUZXIRXEP-MFOYZWKCSA-N |
| Therapeutic Category: | Analgesics, Anti-Inflammatory Agents, Antineoplastic Agents, Antirheumatic Agents, Cyclooxygenase Inhibitors, Enzyme Inhibitors, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 356.418 |
| LogP | : | 4.3655 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 54.37 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Dimethyl sulfoxide (67-68-5) | Neuropathy | Additive | Not Known | Peripheral neuropathy after concomitant dimethyl sulfoxide use and sulindac therapy |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category